Vaag A - Search Results

1

DD2 - nye veje i behandlingen af type 2-diabetes.

Nielsen JS, Rungby J, Christiansen JS, Vaag A, Friborg S, Sørensen HT, Beck-Nielsen H. Nielsen JS, et al. Among authors: vaag a. Ugeskr Laeger. 2014 Jun 2;176(11A):V66222. Ugeskr Laeger. 2014. PMID: 25186673 Free article. Danish. No abstract available.

2

Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.

Vaag AA, Beck-Nielsen H. Vaag AA, et al. Acta Endocrinol (Copenh). 1992 Oct;127(4):344-50. doi: 10.1530/acta.0.1270344. Acta Endocrinol (Copenh). 1992. PMID: 1449046 Clinical Trial.

3

Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H. Vaag A, et al. Diabetologia. 1992 Jan;35(1):80-8. doi: 10.1007/BF00400856. Diabetologia. 1992. PMID: 1541385

4

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Vaag A, Henriksen JE, Beck-Nielsen H. Vaag A, et al. J Clin Invest. 1992 Mar;89(3):782-8. doi: 10.1172/JCI115656. J Clin Invest. 1992. PMID: 1541672 Free PMC article.

5

Insulin resistance in skeletal muscles in patients with NIDDM.

Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Nielsen OH, Henriksen JE, Thye-Rønn P. Beck-Nielsen H, et al. Among authors: vaag a. Diabetes Care. 1992 Mar;15(3):418-29. doi: 10.2337/diacare.15.3.418. Diabetes Care. 1992. PMID: 1559409 Review.

6

Effect of acute hyperglycemia on glucose metabolism in skeletal muscles in IDDM patients.

Vaag A, Hother-Nielsen O, Skött P, Andersen P, Richter EA, Beck-Nielsen H. Vaag A, et al. Diabetes. 1992 Feb;41(2):174-82. doi: 10.2337/diab.41.2.174. Diabetes. 1992. PMID: 1733806

7

Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

Vaag A, Skött P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H. Vaag A, et al. J Clin Invest. 1991 Oct;88(4):1282-90. doi: 10.1172/JCI115432. J Clin Invest. 1991. PMID: 1918378 Free PMC article.

8

Impairment of glucose tolerance: mechanism of action and impact on the cardiovascular system.

Beck-Nielsen H, Hother Nielsen O, Damsbo P, Vaag A, Handberg A, Henriksen JE. Beck-Nielsen H, et al. Among authors: vaag a. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):292-5. doi: 10.1016/0002-9378(90)90570-w. Am J Obstet Gynecol. 1990. PMID: 2115296 Review.

9

Insulin resistance: a risk factor for diabetic complications.

Beck-Nielsen H, Nielsen OH, Damsbo P, Vaag A, Handberg A, Skøtt P, Henriksen JE. Beck-Nielsen H, et al. Among authors: vaag a. J Diabet Complications. 1990 Apr-Jun;4(2):46-8. doi: 10.1016/0891-6632(90)90029-5. J Diabet Complications. 1990. PMID: 2145297 Review. No abstract available.

10

Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H. Vaag A, et al. Diabetologia. 1995 Mar;38(3):326-36. doi: 10.1007/BF00400638. Diabetologia. 1995. PMID: 7758880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page